Cargando…
Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer
Tumor cell-derived hyaluronidase HYAL-1 degrades hyaluronic acid (HA) into angiogenic fragments (AGF: 10-12 disaccharides). AGF support tumor growth and progression. Urine and tissue HAase/HYAL-1 levels are sensitive markers for high-grade bladder cancer (BCa) and its metastasis. In preclinical mode...
Autores principales: | Jordan, Andre R., Lokeshwar, Soum D., Lopez, Luis E., Hennig, Martin, Chipollini, Juan, Yates, Travis, Hupe, Marie C., Merseburger, Axel S., Shiedlin, Aviva, Cerwinka, Wolfgang H., Liu, Kebin, Lokeshwar, Vinata B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421845/ https://www.ncbi.nlm.nih.gov/pubmed/27419371 http://dx.doi.org/10.18632/oncotarget.10529 |
Ejemplares similares
-
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
por: Morera, Daley S, et al.
Publicado: (2017) -
Molecular Oncology of Bladder Cancer from Inception to Modern Perspective
por: Lokeshwar, Soum D., et al.
Publicado: (2022) -
Hyaluronic Acid and Hyaluronidase: Accurate Tumor Markers and Tumor Progression Regulators
por: Lokeshwar, Vinata, et al.
Publicado: (2001) -
Wee1-Hsp90 inhibitor combination treatment: Molecular therapy with potentially broad applicability
por: Lokeshwar, Vinata B.
Publicado: (2012) -
Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma
por: Wang, Jiaojiao, et al.
Publicado: (2022)